Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis

American Journal of Veterinary Research

Volumn 59, Issue 12, 1998, Pages 1537-1539

  Guidry, Albert ^a   Fattom, Ali ^b   Patel, Atul ^b   O'Brien, Celia ^a   Shepherd, Sara ^b   Lohuis, Jos ^c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b Nabi Biopharmaceuticals   (United States)

^c Intervet International   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

AGGLUTINATION TEST; ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLASSIFICATION; EUROPE; FEMALE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MILK; SEROTYPING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

AGGLUTINATION TESTS; ANIMALS; CATTLE; CATTLE DISEASES; EUROPE; FEMALE; MASTITIS, BOVINE; MILK; POLYSACCHARIDES, BACTERIAL; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0032239160     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jasper DE, McDonald JS, Mochrie RD. Bovine mastitis research: Needs, funding and sources of support, in Proceedings. Annu Meet Natl Mastitis Council 1982;21:182-193.
2. Giesecke WH. Mastitis and milk production. In: Technical communication No. 151: Republic of South Africa. Pretoria, South Africa: Department of Agricultural Technical Services, 1979:1-37.
3. Foster TJ. A new genetic approach to defining the virulence determinants of Staphylococcus aureus strains that cause bovine mastitis. Irish Vet J 1986;40:110-115.
4. Norcross NL, Opdebeeck JP. Encapsulation of Staphylococcus aureus isolated from bovine milk. Vet Microbiol 1983;8:397-404.
5. Wilkinson BJ. Staphylococcal capsules and slime. In: Easmon CSF, Adlam C, eds. Staphylococci and staphylococcal infections. London: Academic Press Inc, 1983:481-523.
6. Caputy GG, Costerton JW. Immunological examination of the glycocalyces of Staphylococcus aureus strains Wiley and Smith. Curr Microbiol 1984;11:297-302.
7. Peterson PK, Wilkinson BJ, Kim Y, et al. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 1978;19:943-949
8. Hill AW. Factors influencing the outcome of Escherichia coli mastitis in the dairy cow. Res Vet Sci 1981;31:107-112.
9. Rather PN, Davis AP, Wilkinson BJ. Slime production by bovine milk Staphylococcus aureus and identification of coagulase negative staphylococcal isolates. J Clin Microbiol 1986;23:858-862.
10. Lee JC, Betley MJ, Hopkins CA, et al. Virulence studies in mice of transposon induced mutants of Staphylococcus aureus differing in capsule size. J Inject Dis 1987;156:741-750.
11. Karakawa WW, Sutton A, Schneerson R, et al. Capsular antibodies induce type specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun 1988;56:1090-1095.
12. Guidry AJ, Oliver SP, Squiggins KE, et al. Effect of anti-capsular antibodies on neutrophil phagocytosis of Staphylococcus aureus. J Dairy Sci 1991;74:3360-3369.
13. Guidry AJ, Berning LM, Hambleton CN. Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes. J Dairy Sci 1993;76:1285-1289.
14. Guidry AJ, O'Brien CN, Oliver SP, et al. Effect of whole Staphylococcus aureus and mode of immunization on bovine opsonizing antibodies to capsule. J Dairy Sci 1994;77:2965-2974.
15. Poolman JT. Polysaccharides and membrane vaccines. In: Miziahi A, ed. Bacterial vaccines. New York: Wiley-Liss, 1990:57-86.
16. Fattom A, Schneerson R, Szu SC, et al. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type-5 and type-8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin-A. Infect Immun 1990;58:2367-2374.
17. Fattom A, Shiloach J, Bryla D, et al. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or n-succinimidyl-3-(2-pyridyldithio-propionate). Infect Immun 1992;60:584-589.
18. Fattom A, Schneerson R, Watson DC, et al. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type-5 and type-8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein-A. Infect Immun 1993;61:1023-1032.
19. Karakawa WW, Vann WF. Capsular polysaccharides of Staphylococcus aureus. In: Robbins JB, ed. Bacterial vaccines. New York: Thieme-Stratton, 1982;285-293.
20. Sompolinsky D, Samra Z, Karakawa WW, et al. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol 1985;22:828-834.
21. Poutrel B, Boutonnier A, Sutra L, et al. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow goat and ewe milk. J Clin Microbiol 1988;26:38-40.
22. Guidry AJ, Fattom A, Patel A, et al. Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States. Vet Microbiol 1997;59:53-58.
23. Karakawa WW, Fournier JM, Vann VF, et al. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol 1985;:22:445-447.
24. Knox WD, ed. Milk output in US 1996. Hoard's Dairyman 1997; 142:226.
25. Fattom AI, Naso R. Staphylococcal vaccines: a realistic dream. Ann Med 1996;28:43-46.